Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction

Abstract Acute myocardial infarction (AMI) is a threat to health, with high morbidity and mortality, posing a challenge to the public health system. This study aimed to explore the efficacy and potential targets of Astragaloside IV (AS-IV) combined with Mesenchymal Stem Cells (MSC)-derived exosomes...

詳細記述

書誌詳細

主要な著者:	Sha Zhongxin, Chen Zhijie, Du Feng, Guo Mei Qin, Zhong Ya, Hu Jinxin, Wei Zhang, Yu Zhenqiu
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-07-01
シリーズ:	Scientific Reports
主題:	Astragaloside IV Myocardial infarction Mesenchymal stem cells Exosome PDHA1
オンライン･アクセス:	https://doi.org/10.1038/s41598-025-08628-5
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!